Bufuralol
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Bufuralol
Description :
Bufuralol (Ro 3-4787) is a potent non-selective, orally active β-adrenoreceptor antagonist with partial agonist activity. Bufuralol hydrochloride is a CYP2D6 probe substrate[1][2][3][4].Product Name Alternative :
Ro 3-4787UNSPSC :
12352005Target :
Adrenergic ReceptorType :
Reference compoundRelated Pathways :
GPCR/G Protein; Neuronal SignalingApplications :
Metabolism-protein/nucleotide metabolismField of Research :
Endocrinology; Cardiovascular DiseaseAssay Protocol :
https://www.medchemexpress.com/bufuralol.htmlPurity :
99.25Solubility :
DMSO : 100 mg/mL (ultrasonic; warming; heat to 60°C)Smiles :
CCC1=CC=CC2=C1OC(C(O)CNC(C)(C)C)=C2Molecular Formula :
C16H23NO2Molecular Weight :
261.36References & Citations :
[1]T H Pringle, et al. Pharmacodynamic and pharmacokinetic studies on bufuralol in man. Br J Clin Pharmacol. 1986 Nov;22 (5) :527-34.|[2]Jie Cai, et al. Effects of 22 Novel CYP2D6 Variants Found in the Chinese Population on the Bufuralol and Dextromethorphan Metabolisms In Vitro. Basic Clin Pharmacol Toxicol. 2016 Mar;118 (3) :190-9.|[3]Sarah M Glass, et al. CYP2D6 Allelic Variants *34, *17-2, *17-3, and *53 and a Thr309Ala Mutant Display Altered Kinetics and NADPH Coupling in Metabolism of Bufuralol and Dextromethorphan and Altered Susceptibility to Inactivation by SCH 66712. Drug Metab Dispos. 2018 Aug;46 (8) :1106-1117.|[4]T Prueksaritanont, et al. (+) -bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver. Biochem Pharmacol. 1995 Oct 26;50 (9) :1521-5.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture and light)Scientific Category :
Reference compound1Clinical Information :
No Development ReportedIsoform :
β adrenergic receptorCAS Number :
[54340-62-4]

